App-Quantinova.ai

RETINAL TOXICITY OF ANTIMALARIALS IN RHEUMATOLOGY PRACTICE

D. Palma-Sanchez - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

ARE HYDROXYCHLOROQUINE (HCQ) AND LEFLUNOMIDE (LEF) EFFECTIVE IN DMARD NAIVE PATIENTS WITH EARLY RHEUMATOID ARTHRITIS (RA)?

S. Stoica - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Hydroxychloroquine

COMPARISON OF TOCILIZUMAB AS MONOTHERAPY OR IN COMBINATION WITH NON-BIOLOGICAL DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS (DMARDS) IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA) AND AN INADEQUATE RESPONSE TO ANTI-TNF AGENTS

A. Ostor - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Hydroxychloroquine

EARLY REDUCTION IN SYNOVITIS AND BONE EDEMA EVALUATED BY MRI IN TOCILIZUMAB-TREATED RA PATIENTS WITH INADEQUATE RESPONSE TO ANTI-TNF

M. Lisbona - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Hydroxychloroquine

TOCILIZUMAB USE IN A DIVERSE PATIENT POPULATION: SINGLE-CENTRE TERTIARY EXPERIENCE

S.C. Horton - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Rheumatoid arthritis

Hydroxychloroquine

EFFECTIVENESS AND SAFETY OF SHORT-TERM TREATMENT OF ACTIVE RHEUMATOID ARTHRITIS (RA) MODERATE TO SEVERE WITH TOCILIZUMAB

V. Rodriguez-Garcia - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Hydroxychloroquine

ARTHRITIS WITH CHILDHOOD ONSET IN ADULT PATIENTS

N. Muravieva - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Rheumatoid arthritis

Hydroxychloroquine

CLINICAL SIGNIFICANCE OF SERIAL MEASUREMENT OF ANTI-CITRULLINATED PROTEIN ANTIBODIES (ACPA) IN PATIENTS WITH PALINDROMIC RHEUMATISM

S.R. Cabrera-Villalba - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Hydroxychloroquine

STANDARDIZED MORTALITY RATIOS AND PREDICTORS OF SURVIVAL IN 215 SOUTHERN CHINESE PATIENTS WITH INFLAMMATORY MYOPATHIES

C.H. To - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Interstitial lung disease

Hydroxychloroquine

ESR AS A PREDICTOR OF SLE DISEASE ACTIVITY AND DAMAGE

G. Stojan - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Renal disease

Hydroxychloroquine

HYDROXYCHLOROQUINE REDUCES THROMBOSIS (BOTH ARTERIAL AND VENOUS) IN SYSTEMIC LUPUS ERYTHEMATOSUS, PARTICULARLY IN ANTIPHOSPHOLIPID POSITIVE PATIENTS

G. Law - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

FLARES IN SYSTEMIC LUPUS ERYTHEMATOSUS: ETIOLOGY, OUTCOME AND PROGNOSTIC FACTORS

F. Teixeira - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

A CROSS-SECTIONAL STUDY OF THE DISEASE ACTIVITY AND DAMAGE INDEX OF SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) PATIENTS IN TWO URBAN TERTIARY REFERRAL CENTRES

H.J. Ding - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

DEVELOPMENT OF IDENTIFICATION ALGORITHM FOR SYSTEMIC LUPUS ERYTHEMATOSUS DIAGNOSIS IN THE KOREAN NATIONAL HEALTH INSURANCE CLAIMS DATABASE

J.S. Shim - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

THE CLINICAL AND IMMUNOLOGICAL PROFILE OF SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) PATIENTS IN A MULTIETHNIC MALAYSIAN POPULATION

R. Jasmin - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

AUTOIMMUNE SARCOPENIA IN PATIENTS WITH RHEUMATOID ARTHRITIS AND SYSTEMIC LUPUS ERYTHEMATOSUS

M. Castaneda Urena - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

PREVALENCE AND INCIDENCE OF SYSTEMIC LUPUS EYTHEMATOSUS (SLE) IN SOUTH KOREA

Y.K. Sung - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

VITAMIN D AND CARDIOVASCULAR DISEASE IN SYSTEMIC LUPUS ERYTHEMATOSUS

O.A. Monticielo - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

EFFECTS OF B CELL DEPLETION THERAPY ON CUTANEOUS LUPUS

S.C. Hofmann - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

EFFECT OF ONE CYCLE OF RITUXIMAB IN THE LIPID PROFILE OF PATIENTS WITH REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

L. Nieves-Martin - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

Filters

1151 Abstracts